Chief Medical Officer of Poseida Therapeutics, Inc. (NASDAQ:PSTX), Spear Matthew A., sells 4,000 shares worth $37,747

According to Poseida Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 14 06:18 PM, company Chief Medical Officer, Spear Matthew A. disclosed selling 4,000 shares at a cost of $9.44. At the time of this transaction (Jun 11), this trade was worth $37,747 in total. As of Jun 11, Spear Matthew A. now owns 16,485 shares in total worth about $149,518.95.

For the last few recent trades made by Poseida Therapeutics, Inc. (NASDAQ:PSTX) Chief Medical Officer, Spear Matthew A., we have the following information:

Posted by George Daniels on Tuesday June 15 2021, 10:56 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0